Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
5.38
+0.28 (5.49%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Tenax Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Tenax Therapeutics stock have an average target of 16, which predicts an increase of 197.40% from the current stock price of 5.38.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 24, 2024.
Analyst Ratings
The average analyst rating for Tenax Therapeutics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Leerink Partners | Leerink Partners | Buy Initiates $16 | Buy | Initiates | $16 | +197.40% | Oct 24, 2024 |
Guggenheim | Guggenheim | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +197.40% | Oct 14, 2024 |
William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Sep 30, 2024 |
Roth MKM | Roth MKM | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +457.62% | Feb 20, 2024 |
Roth MKM | Roth MKM | Strong Buy Reiterates $480 | Strong Buy | Reiterates | $480 | +8,821.93% | Nov 13, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.88
from -1.15
EPS Next Year
-0.99
from -0.88
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | 27.1M | ||
Avg | n/a | n/a | 6.6M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.80 | -0.86 | -0.63 | ||
Avg | -0.88 | -0.99 | -0.82 | ||
Low | -0.93 | -1.12 | -0.99 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.